Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00873587 · ClinicalTrials.gov registry record · NA
Clinical Trial Evaluating the Optimal Technique for Chest Tube Removal
A NA study of Chest Tube Removal, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 342
- Enrollment target
- 1
- Study location
NCT00873587: Completed NA study of Chest Tube Removal, sponsored by University of Alabama at Birmingham.
NCT00873587 is a NA study of Chest Tube Removal that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 342 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00873587, a NA study of Chest Tube Removal, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 342 participants
- Enrollment target
- 1
- Study location
Study Summary
There are two commonly used methods to remove chest tubes following thoracotomy. One is to remove the chest tube at maximum inspiration, (patient is asked to take a deep breath in and hold it), and the other is to pull the chest tube at maximum expiration,(patient is asked to blow out as much air as they can can and hold it). There has been considerable discussion among Thoracic surgeons that one of these two methods may decrease the risk of pneumothorax, the most common complication associated with chest tube removal. The investigators will compare the two methods, and also identify risk factors of developing pneumothorax during chest tube removal.
Conditions Studied
Interventions
- PROCEDURE Chest tube pull on inspiration
- PROCEDURE Expiration
Study Locations (1)
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 342 participants |
| Start Date | 2009-03 |
| Est. Completion | 2012-09 |
| Phase | NA |
What the finished NCT00873587 record still lists
NCT00873587 is an interventional study that assigns participants to a tested intervention. The registered 342 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (76% lower).
The record links to 1 condition, with Chest Tube Removal appearing as the primary indexed condition, and to 2 interventions - of which Chest tube pull on inspiration is the first listed.
NCT00873587 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT00873587 about?
NCT00873587 is a clinical study titled "Clinical Trial Evaluating the Optimal Technique for Chest Tube Removal". There are two commonly used methods to remove chest tubes following thoracotomy. One is to remove the chest tube at maximum inspiration, (patient is asked to take a deep breath in and hold it), and the other is to pull the chest tube at maximum expiration,(patient is asked to blow out as much air as...
What is the current status of trial NCT00873587?
This trial is currently completed. It is a NA study. The enrollment target is 342 participants. The study started on 2009-03. Estimated completion is 2012-09.
What conditions does trial NCT00873587 study?
This clinical trial studies the following conditions: Chest Tube Removal.
What interventions are being tested in trial NCT00873587?
The interventions under investigation include: Chest tube pull on inspiration (PROCEDURE), Expiration (PROCEDURE).
Who is sponsoring clinical trial NCT00873587?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00873587 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00873587's enrollment target sits among peer trials
342 302nd of 2000 higher than 1,699 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05283850 · 342 participants · Phase 2
Surviving PEA in Roanoke (SPEAR) Study
- NCT05714085 · 342 participants · Phase 2
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
- NCT06188702 · 342 participants · Phase 1
S095035 as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors With Deletion of MTAP
- NCT06544941 · 342 participants · NA
Improving Maternal Sleep and Mental Health
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia